在基于人群的皮肤黑色素瘤系列中评估TNM第7版与第8版的一致性
研究利用意大利罗马涅癌症登记处2003—2012年1847例皮肤黑色素瘤的人群系列资料,用Cohen kappa衡量TNM第8版与第7版在病理分期上的一致性,并按两版分别计算疾病特异性生存。两版总体一致性较好(kappa=70.7%),I期中等(61.5%),II期近乎完美(95.0%),III期极差(8.1%);黑色素瘤特异性总观察生存5年为90.8%、10年为88.9%,分期预后效应强。
要点
- 两版TNM总体一致性较好(kappa=70.7%),但III期一致性极差(8.1%)。
- II期一致性近乎完美(95.0%),I期中等(61.5%)。
- 黑色素瘤特异性总观察生存5年90.8%、10年88.9%,分期预后效应强。
核心结论
- TNM第8版引入若干变化,似乎对指导I期黑色素瘤的诊疗并无真正帮助,并可能使III期的定义与可比性复杂化。
研究设计与样本
- 基于意大利罗马涅癌症登记处2003—2012年发病的1847例皮肤黑色素瘤人群系列,比较TNM第7版与第8版定义的病理分期。
- 用Cohen kappa衡量TNM第8版与第7版定义黑色素瘤分期的一致性。
- 按TNM第7版与第8版分别计算各期的疾病特异性生存。
主要发现
- 两版TNM平均一致性较好(kappa=70.7%),I期中等(61.5%)。
- II期一致性近乎完美(95.0%),III期一致性极差(8.1%)。
- 黑色素瘤特异性总观察生存5年为90.8%、10年为88.9%,分期预后效应强。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 8th edition of TNM has introduced new rules for staging cutaneous melanoma. OBJECTIVE: To compare TNM 7th and 8th editions in defining pathological stages of melanoma. METHODS: A population-based series of 1847 skin melanoma from Romagna cancer registry (Italy) incident during 2003-2012 has been used to measure the agreement (with Cohen's kappa) between TNM 8th and 7th editions in defining melanoma stage. Disease-specific survival has been computed for each stage according to TNM 7th and 8th. RESULTS: The agreement between the two TNM editions was quite good when considered on average (kappa = 70.7%), moderate for stage I (61.5%), nearly perfect for stage II (95.0%), but extremely poor for stage III (8.1%). The overall melanoma-specific observed survival was 90.8% at 5 year and 88.9% at 10 year with a strong prognostic effect of stage. CONCLUSION: TNM 8th edition introduces several changes which do not seem really helpful in addressing the care of stage I melanoma and may complicate the definition and comparability of stage III.
引用
- Crocetti E, Stanganelli I, Mancini S, et al. Evaluation of the agreement between TNM 7th and 8th in a population-based series of cutaneous melanoma. J Eur Acad Dermatol Venereol. 2018. PMID: 30317667. doi:10.1111/jdv.15285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。